Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Toujeo (previously Optisulin)
Treatment of diabetes mellitus in adults, adolescents and children from the age of 6 years.
